Remixpoint
3825
FUJI Media Holdings
4676
Metaplanet
3350
4
Mitsubishi Heavy Industries
7011
5
Astellas Pharma
4503
(FY)Nov 30, 2023 | |
---|---|
Total revenue | 4.54B |
Operating revenue | --4.54B |
Cost of revenue | 3.99B |
Gross profit | 551.75M |
Operating expense | 512.44M |
Operating profit | 39.3M |
Net non-operating interest income /expenses | -22.21M |
Non-operating interest expense | --22.21M |
Other net income /expenses | |
Special income /charges | --29M |
-Less:Other special charges | ---29M |
Other non-operating income /expenses | --27.75M |
Income before tax | 73.85M |
Income tax | --30.11M |
Net income | 43.74M |
Net income continuous operations | --43.74M |
Net income attributable to the company | 43.74M |
Other under preferred stock dividend | --0 |
Net income attributable to common stockholders | 43.74M |
Diluted earnings per share | --12.5509 |
Basic earnings per share | --12.5509 |
Currency Unit | JPY |